Catheter-based valve implantation techniques are becoming a viable option in various clinical situations to replace difficult redo open heart surgical procedures. This is a report of a first, to our knowledge, successful valve-in-valve (VinV) transcatheter aortic valve implantation (TAVI) into a homograft through the transaortic (TAo) access route using an Edwards SAPIEN valve prosthesis (Edwar...

Pressure half time has been assumed to be a relatively flow-independent measure of orifice area, but it may also be influenced by atrial and ventricular factors. Pressure half time and peak left ventricular inflow velocity were measured by continuous wave Doppler ultrasound in 164 patients with normally functioning Carpentier-Edwards, Björk-Shiley, and Starr-Edwards mitral prostheses. Pressure ...

T ranscatheter aortic valve implantation (TAVI) has become the treatment of choice for symptomatic severe aortic stenosis (AS) in “inoperable” patients and is non-inferior to surgical aortic valve replacement (sAVR) in “high-risk” operable patients.1-4 Since the first-in-human (FIΜ) TAVI in 2002 with the Cribier-Edwards valve, the procedure continues to be refined, with technological improvemen...

Shone, Sellers, Anderson, Adams, Lillehei, and Edwards (1963) descri;bed a developmental deformity of the mitral valve characterized by insertion of the chordae tendineae into a single papillary muscle, producing a funnel-shaped valve which is to some degree stenotic. They employed the term 'parachute' first used by Edwards (1961), and noted an association with other leftsided cardiac deformiti...

A 73-year-old man with permanent atrial fibrillation, coronary artery disease revascularized with coronary artery bypass grafting, mitral valve repair with a 30-mm Carpentier Physio ring (Edwards Lifesciences, Irvine, California), tricuspid valve repair with a 34-mm Edwards MC3 ring (Edwards Lifesciences), and implantation of a 23-mm CarboMedics aortic valve (Sorin Group, Milan, Italy) in 2008 ...

Transcatheter aortic valve replacement in the setting of failed surgical bioprosthesis (valve-in-valve) is a valuable option for patients with bioprosthetic aortic stenosis or regurgitation who are deemed high risk for repeat open heart surgery. Although the procedure is successful with proper preprocedural assessment, instances of left main (LM) coronary artery ostium obstruction have been doc...

Cardiac surgery to treat severe heart failure was of benefit to two patients with endomyocardial disease and hypereosinophilia-eosinophilic endomyocardial disease. Both patients had severe biventricular fibrosis with mitral and tricuspid regurgitation. One had predominant right ventricular disease and was treated by right ventricular endocardectomy with tricuspid and mitral xenograft valve repl...